Enhancing Audit Readiness in Clinical Trial Sites: Practical Insights from Monitoring Experience in India

Abstract

Audit readiness is critical, ensuring patient safety and regulatory compliance in clinical trials. Site monitoring activities play a key role in identifying operational risks and strengthening site preparedness for sponsor audits and regulatory inspections. This article presents practical insights from monitoring experiences across multicenter clinical trial sites in India, demonstrating how operational issues identified were managed through structured corrective and preventive actions. Two real-world monitoring scenarios involving laboratory report misfiling and damaged investigational product shipments are described to illustrate practical implementation approaches at the site level. In the first scenario, laboratory reports filed under an incorrect participant record were identified during monitoring review and addressed through source document reconciliation, verification of investigator oversight, implementation of two-step filing checks, and monitoring verification checkpoints. In the second scenario, a damaged investigational product vial identified upon receipt of the shipment was managed through immediate segregation, inventory reconciliation, sponsor notification, and strengthened receipt-verification procedures before integration into active inventory. These experiences highlight that practical controls such as real-time documentation, role-based verification, structured review steps, and standardized monitoring checks can strengthen traceability, reduce operational errors, and improve site preparedness for audits and inspections.